行情

ENOB

ENOB

Enochian Biosciences
NASDAQ

实时行情|Nasdaq Last Sale

4.050
+0.570
+16.38%
已收盘, 16:00 10/14 EDT
开盘
3.600
昨收
3.480
最高
4.210
最低
3.600
成交量
6.37万
成交额
--
52周最高
9.50
52周最低
2.910
市值
1.87亿
市盈率(TTM)
-7.9583
分时
5日
1月
3月
1年
5年

ENOB 新闻

  • 加州州长要求太平洋瓦电对上周大面积停电负责
  • 新浪美股.2小时前
  • 安永:中国对外直接投资跻身全球第一梯队
  • 中国新闻网.2小时前
  • 毕马威全球颠覆者报告:阿里巴巴等六家中国公司上榜
  • 新浪财经综合.3小时前
  • 数据:伦交所环球板交易工具(CDI)
  • 新浪财经.3小时前

更多

所属板块

生物技术和医学研究
+0.42%
制药与医学研究
+0.09%

热门股票

名称
价格
涨跌幅

ENOB 简况

Enochian Biosciences Inc, formerly DanDrit Biotech USA, Inc., is a Denmark-based biotechnology company. The Company focuses on developing vaccine against colorectal cancer. It has developed various vaccines that are used in various clinical trials in Europe and Asia, including MelCancerVac (MCV) for treatment of cancer (one phase I/II trial in Denmark and two phase II trials in Denmark and Singapore), Tolerogenic (producing immunologic tolerance) dendritic cell (TDC) (pre-clinical stage in Denmark), and Melvaccine (MV), a melanoma cell lysate used as standalone vaccine (pre-clinical state in Denmark). The Company offers MCV platform technology, which is a cellular immunotherapy for treatment of cancer. Also, the Company develops gene therapies for patients with human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS).
展开

Webull提供Enochian Biosciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。